A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics

L Forchette, W Sebastian, T Liu - Current medical science, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of
the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and …

Nanoparticles as antimicrobial and antiviral agents: A literature-based perspective study

S Sharmin, MM Rahaman, C Sarkar, O Atolani… - Heliyon, 2021 - cell.com
The scientific explorations of nanoparticles for their inherent therapeutic potencies as
antimicrobial and antiviral agents due to increasing incidences of antibiotic resistance have …

Recent advances of carbon dots as new antimicrobial agents

P Li, L Sun, S Xue, D Qu, L An, X Wang, Z Sun - SmartMat, 2022 - Wiley Online Library
Due to the COVID‐19 pandemic, many rapid antimicrobial agents have developed
intensively. Carbon dots (CDs), a new type of carbon‐based nanomaterials, shows great …

Structure‐based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles

R De, MK Mahata, KT Kim - Advanced Science, 2022 - Wiley Online Library
Carriers are equally important as drugs. They can substantially improve bioavailability of
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …

Exploration of nanozymes in viral diagnosis and therapy

J Lee, H Liao, Q Wang, J Han, JH Han, HE Shin… - …, 2022 - Wiley Online Library
Nanozymes are nanomaterials with similar catalytic activities to natural enzymes. Compared
with natural enzymes, they have numerous advantages, including higher physiochemical …

Multifunctional iron oxide magnetic nanoparticles for biomedical applications: a review

HV Tran, NM Ngo, R Medhi, P Srinoi, T Liu… - Materials, 2022 - mdpi.com
Due to their good magnetic properties, excellent biocompatibility, and low price, magnetic
iron oxide nanoparticles (IONPs) are the most commonly used magnetic nanomaterials and …

Current and future nanoparticle vaccines for COVID-19

MN Vu, HG Kelly, SJ Kent, AK Wheatley - EBioMedicine, 2021 - thelancet.com
COVID-19 has become a major cause of global mortality and driven massive health and
economic disruptions. Mass global vaccination offers the most efficient pathway towards …

[HTML][HTML] Sustained delivery approaches to improving adaptive immune responses

BS Ou, OM Saouaf, J Baillet, EA Appel - Advanced Drug Delivery Reviews, 2022 - Elsevier
The immune system is one of the most important, complex biological networks regulating
and protecting human health. Its precise modulation can prevent deadly infections and fight …

Advances in nanomaterial-based platforms to combat COVID-19: Diagnostics, preventions, therapeutics, and vaccine developments

N Mahmud, MI Anik, MK Hossain, MI Khan… - ACS Applied Bio …, 2022 - ACS Publications
The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …

Nanovaccine: An emerging strategy

A Das, N Ali - Expert review of vaccines, 2021 - Taylor & Francis
Introduction Vaccination is so far the most effective way of eradicating infections. Rapidly
emerging drug resistance against infectious diseases and chemotherapy-related toxicities in …